Press Releases

TxCell SA, a clinical stage biotechnology company developing innovative, personalized cell-based immunotherapies using antigen-specific regulatory T-cells (Ag-Tregs) for chronic inflammatory and autoimmune diseases, announces today that Damian Marron, CEO, TxCell, will present at BIO CEO & Investor Conference 2014....

US-based pharmaceutical firm dedicated to the commercialization of oncology treatment and oncology supportive care products DARA BioSciences has signed a pharmacy supply agreement with RainTree Oncology Services. The agreement is for both Gelclair,...

Their joint aim is to identify new therapeutic targets in ‘triple negative’ breast cancers Paris and Suresnes, France, January 28, 2014 – Curie-Cancer, the body which leads the Institut Curie's industry partner research activity, and Servier, today announce that...

Study results provide positive data for ongoing human trials Reading and Oxford, UK, January 23, 2014 – Clasado, the manufacturers and suppliers of the second generation prebiotic Bimuno®, and The Department of Psychiatry, University of Oxford, today announce...

Canada-based Domain Therapeutics NA Inc. will focus exclusively on leveraging the BioSens-All(TM) technologyStrasbourg, France and Montreal, Canada, January 20, 2014 – Domain Therapeutics, a biopharmaceutical company specializing in the research and development of new drug candidates targeting G protein-coupled...

NanoLogix Inc. an innovator in the rapid detection identification and determination of antibiotic resistance and sensitivity of live bacteria announces that the State of Ohio Department of Economic Development’s International Trade Assistance Center (ITAC) based at Youngstown State University...

Strasbourg, France and Montreal, Canada, January 20, 2014 – Domain Therapeutics, a biopharmaceutical company specializing in the research and development of new drug candidates targeting G protein-coupled receptors (GPCRs), today announces the opening of its North American...